Page last updated: 2024-09-05

sorafenib and l 660,711

sorafenib has been researched along with l 660,711 in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(l 660,711)
Trials
(l 660,711)
Recent Studies (post-2010) (l 660,711)
6,5207305,25145012

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)l 660,711 (IC50)
ATP-binding cassette sub-family C member 3Homo sapiens (human)9.3
Multidrug resistance-associated protein 4Homo sapiens (human)8
Solute carrier organic anion transporter family member 2B1 Homo sapiens (human)2.9
Bile salt export pumpHomo sapiens (human)3.515
Multidrug resistance-associated protein 1 Homo sapiens (human)2.9733
Canalicular multispecific organic anion transporter 1Rattus norvegicus (Norway rat)2.62
Canalicular multispecific organic anion transporter 1Homo sapiens (human)7
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)6.4
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)4.4

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF1

Reviews

1 review(s) available for sorafenib and l 660,711

ArticleYear
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells

2022

Other Studies

1 other study(ies) available for sorafenib and l 660,711

ArticleYear
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010